Insulin Glargine U100 Utilization in Patients with Type 2 Diabetes in an Italian Real-World Setting: A Retrospective Study

Table 4

Daily mean insulin dose according to HbA1c levels in the insulin glargine only cohort ().

		Daily mean insulin dose (IU)				Total
		<20 IU	20 IU-29 IU	30 IU-39 IU	≥40 IU
Last HbA1c during follow-up (%)	<7.0%	46.7	33.3	58.3	63.1	53.8
		25.3	—	16.7	15.4	19.6
		17.3	33.3	8.3	9.2	13.9
	≥9.0%	10.7	33.3	16.7	12.3	12.7

The analysis was carried out on the cohort of patients for which laboratory data were available and with at least 3 months of follow-up. The last value of HbA1c during the follow-up period was considered. among different levels of HbA1c and daily mean insulin dose.